Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients.
B. Jimenez
No relevant relationships to disclose
J. M. Trigo Perez
No relevant relationships to disclose
M. I. Saez Medina
No relevant relationships to disclose
C. Quero Blanco
No relevant relationships to disclose
B. Pajares
No relevant relationships to disclose
A. Rueda
No relevant relationships to disclose
E. Alba
No relevant relationships to disclose